Status:

UNKNOWN

Symptom Collection of Lung Cancer Patients

Lead Sponsor:

Seong-Gyu Ko

Conditions:

Lung Cancer

Eligibility:

All Genders

18+ years

Brief Summary

This study is conducted to collect the symptoms of lung cancer patients and to observe the relationship with proteomics.

Eligibility Criteria

Inclusion

  • Adult over 18 years old
  • Patients are scheduled for surgery with lung cancer diagnosis.
  • ECOG status score 0 to 2
  • Individual who can read and understand Korean
  • Participant is willing and able to give informed consent for participation in the study

Exclusion

  • Patient who was diagnosed with lung cancer in the past.
  • Individuals who are judged inappropriate for the study

Key Trial Info

Start Date :

September 16 2015

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

May 31 2018

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT03384680

Start Date

September 16 2015

End Date

May 31 2018

Last Update

January 9 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Korea University Guro Hospital

Seoul, South Korea